Exercise-based cardiac rehabilitation (CR) reduces the risk of hospital admissions and improves the quality of life (QoL), aerobic and walking capacity, and muscle strength in patients with congestive heart failure (CHF).1 According to EAPC/ESC recommendations, low intense (LI) to moderate intense (MI) endurance exercises should be supplemented by dynamic resistance exercises [40–60% of 1-maximal repetition (1RM)].2 Currently, the optimal intensity of these resistance exercises has not been experimentally established in HF. In coronary artery disease (CAD), however, MI resistance exercise training (combined with endurance exercise training) is superior to LI resistance exercise training to improve muscle strength.3 Therefore, in this study, we investigate the effects of LI vs. MI resistance training, combined with endurance training, on aerobic fitness, walking capacity, muscle strength, and QoL in patients with CHF, and hypothesize that MI resistance exercise training might be superior to LI resistance training.

In this randomized clinical trial (NCT04688827), participants were recruited consecutively upon initiation of the CR programme and they were referred independently from acute events (see Supplementary material online, Figure S1). Eligible participants were men and women >18 years, with an echocardiographic diagnosis of CHF independent of left ventricular ejection fraction, without ventricular assist device. Participants with (i) orthopaedic or neurological comorbidities affecting strength, (ii) cognitive impairment, and/or (iii) lung disease (e.g. chronic obstructive pulmonary disease) were ineligible. All participants gave their informed consent. The assessments were done before or in the first 2 weeks of the CR programme and during/after the last training week. An independent researcher block-stratified participants [size 2–4; factors: age (</≥50) and sex (M/F) via ‘sealedenvelope.com’ to LI or MI resistance exercise training plus endurance exercise training group (MI).

The participants followed a CR programme of 45 supervised sessions (3×/week). The sessions comprised of ∼20–40 min of endurance exercises [on treadmill, cycle/arm ergometer, stepper, cross-trainer, and/or rowing machine (at ∼50–75% of VO2peak)] and ∼15–25 min of resistance exercises. Resistance exercises in the MI group included 3 × 12 repetitions of leg press, dips, and pulldown at 55–70%1RM, while the LI group did 3 × 18–22 repetitions at 35–40%1RM. Resistance exercises were volume-matched between groups [volume = intensity (%1RM) × repetitions].

The main outcomes were changes of aerobic capacity (peak oxygen consumption = VO2peak), walking capacity [6 min walk test distance (6MWTdistance)], muscle strength (1RM), and QoL.

A cardiopulmonary exercise test (ramp protocol: +5–30 W/min) with 12-lead electrocardiogram (GE Medical Systems, Germany) was done on a bicycle ergometer to determine the 10 s averaged VO2peak and peak heart rate (HRpeak).

For assessing muscle strength, a 1RM trial was repeated ≤5 times with 1 min between-set rests, and Brzycki’s formula was used to estimate the 1RM.4 1-Maximal repetition was reassessed every nine exercise sessions to allow progression. A 6MWT was done in the hospital hallway between the two cones 30 m apart.5 The QoL was assessed with the Minnesota-Living with Heart Failure questionnaire (Minnesota) during supervised hospital visits.6 The total score was a sum of 21 questions on a 0–5 Likert scale. Total scores were categorized into low (>45 points), moderate (24–45 points), or high QoL (<24 points).7 Changes in the physical (q2–7 and 12–13),8 social (q8–10 and 14–16),9 and emotional component (q17–21)8,9 were evaluated.

Normality was assessed by using the Shapiro–Wilk test (IBM-SPSS-Statistics-v28.0.1.1.). An independent t-test, Mann–Whitney U test, or Fisher’s exact test were used for the between-group analysis at baseline and for pre-post changes, while the paired t-test, Wilcox sign-rank test, and McNemar’s χ2 test were used for testing changes within groups (two-tailed significance level P < 0.05).

Groups had similar baseline characteristics and training adherence (Table 1).

Table 1

Baseline characteristics

VariablesnLI (n = 28)nMI (n = 28)P-value
Male sex (n/%)23 (82)23 (82)1.000
Age (years)2863 (15)2864 (14)0.417
Height (cm)28173 ± 928172 ± 80.391
Body mass (kg)2886 ± 152879 ± 140.105
BMI (kg/m2)2828 ± 42827 ± 40.173
LVEF (%)2438 ± 92439 ± 110.720
LVEF (≥50%, 41–49%, ≤ 40%, unknown; n)284/6/14/4284/11/9/4
DD (grade I/2/unclear)2816/7/52824/2/2
Training adherence (tc)2840 ± 72835 ± 100.119
Devices
 PM2813 (46)2811 (39)0.787
 CRT + ICD combined285 (18)284 (14)>0.99
Smoking
 Smoker282 (7)282 (7)>0.99
 Ex-smoker2814 (50)2812 (43)0.789
Comorbidities and risk factors
 Arterial hypertension2816 (57)2818 (64)0.784
 Diabetes (T2DM)283 (11)287 (25)0.296
 Dyslipidaemia2818 (64)2820 (67)0.451
 Obesity2810 (36)285 (18)0.227
 OSA285 (18)284 (13)>0.99
Medication
 Beta-blocker2727 (96)2524 (86)0.481
 ACE inhibitors2713 (46)2515 (54)0.419
 Statins2722 (76)2520 (71)>0.99
 Diuretics2716 (82)2512 (43)0.578
 ARB2712 (43)257 (25)0.259
 Antiarrhythmics275 (18)251 (3)0.193
VariablesnLI (n = 28)nMI (n = 28)P-value
Male sex (n/%)23 (82)23 (82)1.000
Age (years)2863 (15)2864 (14)0.417
Height (cm)28173 ± 928172 ± 80.391
Body mass (kg)2886 ± 152879 ± 140.105
BMI (kg/m2)2828 ± 42827 ± 40.173
LVEF (%)2438 ± 92439 ± 110.720
LVEF (≥50%, 41–49%, ≤ 40%, unknown; n)284/6/14/4284/11/9/4
DD (grade I/2/unclear)2816/7/52824/2/2
Training adherence (tc)2840 ± 72835 ± 100.119
Devices
 PM2813 (46)2811 (39)0.787
 CRT + ICD combined285 (18)284 (14)>0.99
Smoking
 Smoker282 (7)282 (7)>0.99
 Ex-smoker2814 (50)2812 (43)0.789
Comorbidities and risk factors
 Arterial hypertension2816 (57)2818 (64)0.784
 Diabetes (T2DM)283 (11)287 (25)0.296
 Dyslipidaemia2818 (64)2820 (67)0.451
 Obesity2810 (36)285 (18)0.227
 OSA285 (18)284 (13)>0.99
Medication
 Beta-blocker2727 (96)2524 (86)0.481
 ACE inhibitors2713 (46)2515 (54)0.419
 Statins2722 (76)2520 (71)>0.99
 Diuretics2716 (82)2512 (43)0.578
 ARB2712 (43)257 (25)0.259
 Antiarrhythmics275 (18)251 (3)0.193

Normally distributed data are means ± standard deviations (SDs), non-normally distributed data are medians, frequencies are n (%).

ACE, angiotensin-converting enzyme; LIG, low-intense resistance training group; MIG, moderate-intense resistance training group; tc, trainings completed out of maximal 45; BMI, body mass index; LVEF, left ventricle ejection fraction; DD, diastolic dysfunction; PM, pacemaker; CRT, cardiac resynchronization therapy; ICD, implantable cardioverter-defibrillator; OSA, obstructive sleep apnoea.

Table 1

Baseline characteristics

VariablesnLI (n = 28)nMI (n = 28)P-value
Male sex (n/%)23 (82)23 (82)1.000
Age (years)2863 (15)2864 (14)0.417
Height (cm)28173 ± 928172 ± 80.391
Body mass (kg)2886 ± 152879 ± 140.105
BMI (kg/m2)2828 ± 42827 ± 40.173
LVEF (%)2438 ± 92439 ± 110.720
LVEF (≥50%, 41–49%, ≤ 40%, unknown; n)284/6/14/4284/11/9/4
DD (grade I/2/unclear)2816/7/52824/2/2
Training adherence (tc)2840 ± 72835 ± 100.119
Devices
 PM2813 (46)2811 (39)0.787
 CRT + ICD combined285 (18)284 (14)>0.99
Smoking
 Smoker282 (7)282 (7)>0.99
 Ex-smoker2814 (50)2812 (43)0.789
Comorbidities and risk factors
 Arterial hypertension2816 (57)2818 (64)0.784
 Diabetes (T2DM)283 (11)287 (25)0.296
 Dyslipidaemia2818 (64)2820 (67)0.451
 Obesity2810 (36)285 (18)0.227
 OSA285 (18)284 (13)>0.99
Medication
 Beta-blocker2727 (96)2524 (86)0.481
 ACE inhibitors2713 (46)2515 (54)0.419
 Statins2722 (76)2520 (71)>0.99
 Diuretics2716 (82)2512 (43)0.578
 ARB2712 (43)257 (25)0.259
 Antiarrhythmics275 (18)251 (3)0.193
VariablesnLI (n = 28)nMI (n = 28)P-value
Male sex (n/%)23 (82)23 (82)1.000
Age (years)2863 (15)2864 (14)0.417
Height (cm)28173 ± 928172 ± 80.391
Body mass (kg)2886 ± 152879 ± 140.105
BMI (kg/m2)2828 ± 42827 ± 40.173
LVEF (%)2438 ± 92439 ± 110.720
LVEF (≥50%, 41–49%, ≤ 40%, unknown; n)284/6/14/4284/11/9/4
DD (grade I/2/unclear)2816/7/52824/2/2
Training adherence (tc)2840 ± 72835 ± 100.119
Devices
 PM2813 (46)2811 (39)0.787
 CRT + ICD combined285 (18)284 (14)>0.99
Smoking
 Smoker282 (7)282 (7)>0.99
 Ex-smoker2814 (50)2812 (43)0.789
Comorbidities and risk factors
 Arterial hypertension2816 (57)2818 (64)0.784
 Diabetes (T2DM)283 (11)287 (25)0.296
 Dyslipidaemia2818 (64)2820 (67)0.451
 Obesity2810 (36)285 (18)0.227
 OSA285 (18)284 (13)>0.99
Medication
 Beta-blocker2727 (96)2524 (86)0.481
 ACE inhibitors2713 (46)2515 (54)0.419
 Statins2722 (76)2520 (71)>0.99
 Diuretics2716 (82)2512 (43)0.578
 ARB2712 (43)257 (25)0.259
 Antiarrhythmics275 (18)251 (3)0.193

Normally distributed data are means ± standard deviations (SDs), non-normally distributed data are medians, frequencies are n (%).

ACE, angiotensin-converting enzyme; LIG, low-intense resistance training group; MIG, moderate-intense resistance training group; tc, trainings completed out of maximal 45; BMI, body mass index; LVEF, left ventricle ejection fraction; DD, diastolic dysfunction; PM, pacemaker; CRT, cardiac resynchronization therapy; ICD, implantable cardioverter-defibrillator; OSA, obstructive sleep apnoea.

VO2peak, 6MWT distance, and 1-RM significantly increased within groups (P < 0.001), and similarly between groups (P > 0.05, Table 2). The total score of Minnesota and the separate scores for the physical, emotional, and social components significantly improved in the LI group (P ≤ 0.01; Table 2), but not in the MI group (P > 0.09). Only the emotional component improved significantly more in the LI than the MI group (P = 0.048), and there were more patients with a high QoL in the LI (P = 0.008), but not in the MI group (P = 0.480) after the intervention.

Table 2

Changes of aerobic and walking capacity, muscle strength, and quality of life

VariablenLI (n = 28)ChangeP-valuenMI (n = 28)ChangeP-valueP-value
PrePostWithin LIPrePostWithin MIBetween
Cardiopulmonary exercise test
 VO2peak (mL/kg/min)2816.5 (9.3)19.4 (7.5)3.9 (2.62)<0.0012817.1 (9.3)21.4 (9.0)3.25 (4.85)<0.0010.731
 Load (W)28120 (66)144 (60)22 (26)<0.00128116 (79)124 (82)25 (25)<0.0010.883
 HRmax (b.p.m.)28108 ± 22a118 + 267.1 ± 12.10.00228124 ± 23124 ± 210.3 (22)0.9360.016
6-min walk test
 Distance (m)28473 (117)508 (142)31.5 (43)<0.00127507 (134570 (104)46.5 (71)<0.0010.794
 HR (b.p.m.)2878 (22)85 (24)18 (23)0.0912784 (28)92 (35)22 (25)0.7150.933
 Saturation (%)2798 (3)98 (3)−0.5 (3)0.3122698 (2)98 (1)0 (2)0.4770.276
Muscle strength—1RM
 Dip (kg)2876 (24)87 (47)10.5 (18)<0.0012775 (29)82 (32)12.5 (21)<0.0010.573
 Leg-press (kg)25126 (90)167 (107)32 (48)<0.00126136 (70)153 (111)22.5 (30)<0.0010.699
 Pulldown (kg)2767 ± 1774 ± 184 (12)<0.0012763 ± 1971 ± 187.5 (8)<0.0010.430
Quality of life—Minnesota questionnaire
 Physical score (points)2210 (12)5.5 (5)−3 (9)0.005236 (18)5 (8)−1 (8)0.2590.184
 Social score (points)214 (13)2 (4)−3.5 (7)0.004233 (12)3 (7)−0.5 (8)0.0930.233
 Emotional score (points)236 (9)2 (4)−2 (7)0.002233 (10)2 (4)0 (4)0.6370.048
 Total score (points)1915 (31)9 (12)−7 (21)0.0162115 (47)13 (29)−1.5 (16)0.3900.236
 Low QoL (n, %)191 (5)0 (0)−10.480215 (22)3 (14)−21.0000.233
 Moderate QoL (n, %)199 (47)2 (11)−70.023212 (8)5 (24)+30.3710.414
 High QoL (n, %)1910 (53)18 (95)+80.0082116 (70)15 (71)−10.4800.095
VariablenLI (n = 28)ChangeP-valuenMI (n = 28)ChangeP-valueP-value
PrePostWithin LIPrePostWithin MIBetween
Cardiopulmonary exercise test
 VO2peak (mL/kg/min)2816.5 (9.3)19.4 (7.5)3.9 (2.62)<0.0012817.1 (9.3)21.4 (9.0)3.25 (4.85)<0.0010.731
 Load (W)28120 (66)144 (60)22 (26)<0.00128116 (79)124 (82)25 (25)<0.0010.883
 HRmax (b.p.m.)28108 ± 22a118 + 267.1 ± 12.10.00228124 ± 23124 ± 210.3 (22)0.9360.016
6-min walk test
 Distance (m)28473 (117)508 (142)31.5 (43)<0.00127507 (134570 (104)46.5 (71)<0.0010.794
 HR (b.p.m.)2878 (22)85 (24)18 (23)0.0912784 (28)92 (35)22 (25)0.7150.933
 Saturation (%)2798 (3)98 (3)−0.5 (3)0.3122698 (2)98 (1)0 (2)0.4770.276
Muscle strength—1RM
 Dip (kg)2876 (24)87 (47)10.5 (18)<0.0012775 (29)82 (32)12.5 (21)<0.0010.573
 Leg-press (kg)25126 (90)167 (107)32 (48)<0.00126136 (70)153 (111)22.5 (30)<0.0010.699
 Pulldown (kg)2767 ± 1774 ± 184 (12)<0.0012763 ± 1971 ± 187.5 (8)<0.0010.430
Quality of life—Minnesota questionnaire
 Physical score (points)2210 (12)5.5 (5)−3 (9)0.005236 (18)5 (8)−1 (8)0.2590.184
 Social score (points)214 (13)2 (4)−3.5 (7)0.004233 (12)3 (7)−0.5 (8)0.0930.233
 Emotional score (points)236 (9)2 (4)−2 (7)0.002233 (10)2 (4)0 (4)0.6370.048
 Total score (points)1915 (31)9 (12)−7 (21)0.0162115 (47)13 (29)−1.5 (16)0.3900.236
 Low QoL (n, %)191 (5)0 (0)−10.480215 (22)3 (14)−21.0000.233
 Moderate QoL (n, %)199 (47)2 (11)−70.023212 (8)5 (24)+30.3710.414
 High QoL (n, %)1910 (53)18 (95)+80.0082116 (70)15 (71)−10.4800.095

Data are mean ± SD or median (interquartile) or n (% group); Change = post-pre.

LI, low-intense group; MI, moderate-intense group; high QoL, Score 0–23; moderate QoL, Score 24–45; low QoL, Score >45.

aDifference between groups at baseline (P < 0.05); between-group differences in pre-post changes, Mann–Whitney U test, independent t-test or Fisher’s exact test; within-group differences, paired t-test, Wilcox sign-rank, and McNemar χ2

Table 2

Changes of aerobic and walking capacity, muscle strength, and quality of life

VariablenLI (n = 28)ChangeP-valuenMI (n = 28)ChangeP-valueP-value
PrePostWithin LIPrePostWithin MIBetween
Cardiopulmonary exercise test
 VO2peak (mL/kg/min)2816.5 (9.3)19.4 (7.5)3.9 (2.62)<0.0012817.1 (9.3)21.4 (9.0)3.25 (4.85)<0.0010.731
 Load (W)28120 (66)144 (60)22 (26)<0.00128116 (79)124 (82)25 (25)<0.0010.883
 HRmax (b.p.m.)28108 ± 22a118 + 267.1 ± 12.10.00228124 ± 23124 ± 210.3 (22)0.9360.016
6-min walk test
 Distance (m)28473 (117)508 (142)31.5 (43)<0.00127507 (134570 (104)46.5 (71)<0.0010.794
 HR (b.p.m.)2878 (22)85 (24)18 (23)0.0912784 (28)92 (35)22 (25)0.7150.933
 Saturation (%)2798 (3)98 (3)−0.5 (3)0.3122698 (2)98 (1)0 (2)0.4770.276
Muscle strength—1RM
 Dip (kg)2876 (24)87 (47)10.5 (18)<0.0012775 (29)82 (32)12.5 (21)<0.0010.573
 Leg-press (kg)25126 (90)167 (107)32 (48)<0.00126136 (70)153 (111)22.5 (30)<0.0010.699
 Pulldown (kg)2767 ± 1774 ± 184 (12)<0.0012763 ± 1971 ± 187.5 (8)<0.0010.430
Quality of life—Minnesota questionnaire
 Physical score (points)2210 (12)5.5 (5)−3 (9)0.005236 (18)5 (8)−1 (8)0.2590.184
 Social score (points)214 (13)2 (4)−3.5 (7)0.004233 (12)3 (7)−0.5 (8)0.0930.233
 Emotional score (points)236 (9)2 (4)−2 (7)0.002233 (10)2 (4)0 (4)0.6370.048
 Total score (points)1915 (31)9 (12)−7 (21)0.0162115 (47)13 (29)−1.5 (16)0.3900.236
 Low QoL (n, %)191 (5)0 (0)−10.480215 (22)3 (14)−21.0000.233
 Moderate QoL (n, %)199 (47)2 (11)−70.023212 (8)5 (24)+30.3710.414
 High QoL (n, %)1910 (53)18 (95)+80.0082116 (70)15 (71)−10.4800.095
VariablenLI (n = 28)ChangeP-valuenMI (n = 28)ChangeP-valueP-value
PrePostWithin LIPrePostWithin MIBetween
Cardiopulmonary exercise test
 VO2peak (mL/kg/min)2816.5 (9.3)19.4 (7.5)3.9 (2.62)<0.0012817.1 (9.3)21.4 (9.0)3.25 (4.85)<0.0010.731
 Load (W)28120 (66)144 (60)22 (26)<0.00128116 (79)124 (82)25 (25)<0.0010.883
 HRmax (b.p.m.)28108 ± 22a118 + 267.1 ± 12.10.00228124 ± 23124 ± 210.3 (22)0.9360.016
6-min walk test
 Distance (m)28473 (117)508 (142)31.5 (43)<0.00127507 (134570 (104)46.5 (71)<0.0010.794
 HR (b.p.m.)2878 (22)85 (24)18 (23)0.0912784 (28)92 (35)22 (25)0.7150.933
 Saturation (%)2798 (3)98 (3)−0.5 (3)0.3122698 (2)98 (1)0 (2)0.4770.276
Muscle strength—1RM
 Dip (kg)2876 (24)87 (47)10.5 (18)<0.0012775 (29)82 (32)12.5 (21)<0.0010.573
 Leg-press (kg)25126 (90)167 (107)32 (48)<0.00126136 (70)153 (111)22.5 (30)<0.0010.699
 Pulldown (kg)2767 ± 1774 ± 184 (12)<0.0012763 ± 1971 ± 187.5 (8)<0.0010.430
Quality of life—Minnesota questionnaire
 Physical score (points)2210 (12)5.5 (5)−3 (9)0.005236 (18)5 (8)−1 (8)0.2590.184
 Social score (points)214 (13)2 (4)−3.5 (7)0.004233 (12)3 (7)−0.5 (8)0.0930.233
 Emotional score (points)236 (9)2 (4)−2 (7)0.002233 (10)2 (4)0 (4)0.6370.048
 Total score (points)1915 (31)9 (12)−7 (21)0.0162115 (47)13 (29)−1.5 (16)0.3900.236
 Low QoL (n, %)191 (5)0 (0)−10.480215 (22)3 (14)−21.0000.233
 Moderate QoL (n, %)199 (47)2 (11)−70.023212 (8)5 (24)+30.3710.414
 High QoL (n, %)1910 (53)18 (95)+80.0082116 (70)15 (71)−10.4800.095

Data are mean ± SD or median (interquartile) or n (% group); Change = post-pre.

LI, low-intense group; MI, moderate-intense group; high QoL, Score 0–23; moderate QoL, Score 24–45; low QoL, Score >45.

aDifference between groups at baseline (P < 0.05); between-group differences in pre-post changes, Mann–Whitney U test, independent t-test or Fisher’s exact test; within-group differences, paired t-test, Wilcox sign-rank, and McNemar χ2

This study shows for the first time that LI and MI resistance exercise training, combined with endurance exercise training, are equally effective in improving VO2peak, walking capacity, muscle strength, and QoL in patients with CHF.

The lack of differences in changes of aerobic capacity between groups is in line with data from CAD.3 The likely driver of changes in the aerobic capacity is better peripheral oxygen extraction or increased left ventricle ejection fraction primarily due to endurance training.10,11

In contrast to healthy adults12 and patients with CAD,3 both training regimes were equally effective in improving muscle strength in patients with CHF. Since training intensity drives improvements in muscle strength in older adults12 and CAD,3 MI resistance training from this study (65%1RM) might have been too similar to LI resistance training (35–40%1RM) to induce superior improvements in strength, although these are the guideline-directed lower and upper ranges of resistance exercise training.2 The QoL improved in the LI group and improvements were in the range of the MCID of −8.2 points from the ROC analysis,13 and −9.82 points from other combined-modality exercise-rehabilitation studies in HF.14 Considering that the full-intervention potential might have been partially masked in this study by too-similar resistance training programmes, future studies should focus on comparing the effects of volume-matched high intense (>65%1RM) vs. LI to MI resistance training programmes combined with endurance training.

In conclusion, LI and MI resistance exercise training, combined with endurance exercise training, similarly improves VO2peak, walking capacity, and muscle strength, but LI resistance exercise training might be superior in improving QoL in patients with CHF.

Supplementary material

Supplementary material is available at European Journal of Preventive Cardiology.

Funding

This research was supported by the internal funding from the Faculty of Rehabilitation Sciences of Hasselt University (Belgium) and by the Ziekenhuis Oost-Limburg Genk (Belgium).

Data availability

The data underlying this article will be shared on reasonable request to the corresponding author.

Authors’ contributions

T.G., K.G., N.T.D.S., B.T., W.M., and D.H. contributed to the conception or design of the work. T.G., K.G., B.T., and N.T.D.S. contributed to the acquisition, analysis, or interpretation of data for the work. T.G., K.G., and D.H. drafted the manuscript. Everyone critically revised the manuscript, gave final approval, and agreed to be accountable for all aspects of work ensuring integrity and accuracy.

References

1

Long
L
,
Mordi
IR
,
Bridges
C
,
Sagar
VA
,
Davies
EJ
,
Coats
AJS
, et al.
Exercise-based cardiac rehabilitation for adults with heart failure
.
Cochrane Database Syst Rev
2019
;
2019
:
CD003331
.

2

Ambrosetti
M
,
Abreu
A
,
Corrà
U
,
Davos
CH
,
Hansen
D
,
Frederix
I
, et al.
Secondary prevention through comprehensive cardiovascular rehabilitation: from knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology
.
Eur J Prev Cardiol
2021
;
28
:
460
495
.

3

Kambic
T
,
Šarabon
N
,
Hadžić
V
,
Lainscak
M
.
Effects of high- and low-load resistance training in patients with coronary artery disease: a randomized controlled clinical trial
.
Eur J Prev Cardiol
2022
;
29
:
E338
E342
.

4

Brzycki
M
.
Strength testing—predicting a one-rep max from reps-to-fatigue
.
J Phys Educ Recreat Dance
1993
;
64
:
88
90
.

5

Uszko-Lencer
NHMK
,
Mesquita
R
,
Janssen
E
,
Werter
C
,
Brunner-La Rocca
H-P
,
Pitta
F
, et al.
Reliability, construct validity and determinants of 6-minute walk test performance in patients with chronic heart failure
.
Int J Cardiol
2017
;
240
:
285
290
.

6

Bilbao
A
,
Escobar
A
,
García-Perez
L
,
Navarro
G
,
Quirós
R
.
The Minnesota living with heart failure questionnaire: comparison of different factor structures
.
Health Qual Life Outcomes
2016
;
14
:
23
.

7

Behlouli
H
,
Deborah
EF
,
Ducharme
A
,
Frenette
M
,
Giannetti
N
,
Grondin
F
, et al.
Identifying relative cut-off scores with neural networks for interpretation of the Minnesota Living with Heart Failure questionnaire
.
Annu Int Conf IEEE Eng Med Biol Soc
2009
;
2009
:
6242
6246
.

8

Rector
TS
,
Cohn
JN
.
Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan
.
Am Heart J
1992
;
124
:
1017
1025
.

9

Munyombwe
T
,
Höfer
S
,
Fitzsimons
D
,
Thompson
DR
,
Lane
D
,
Smith
K
, et al.
An evaluation of the Minnesota Living with Heart Failure Questionnaire using Rasch analysis
.
Qual Life Res
2014
;
23
:
1753
1765
.

10

Tucker
WJ
,
Beaudry
RI
,
Liang
Y
,
Clark
AM
,
Tomczak
CR
,
Nelson
MD
, et al.
Meta-analysis of exercise training on left ventricular ejection fraction in heart failure with reduced ejection fraction: a 10-year update
.
Prog Cardiovasc Dis
2019
;
62
:
163
171
.

11

Santos
FV
,
Chiappa
GR
,
Ramalho
SHR
,
de Lima
ACGB
,
de Souza
FSJ
,
Cahalin
LP
, et al.
Resistance exercise enhances oxygen uptake without worsening cardiac function in patients with systolic heart failure: a systematic review and meta-analysis
.
Heart Fail Rev
2018
;
23
:
73
89
.

12

Fragala
MS
,
Cadore
EL
,
Dorgo
S
,
Izquierdo
M
,
Kraemer
WJ
,
Peterson
MD
, et al.
Resistance training for older adults: position statement from the national strength and conditioning association
.
J Strength Cond Res
2019
;
33
:
2019
2052
.

13

Gonzalez-Saenz De Tejada
M
,
Bilbao
A
,
Ansola
L
,
Quirós
R
,
García-Perez
L
,
Navarro
G
, et al.
Responsiveness and minimal clinically important difference of the Minnesota living with heart failure questionnaire
.
Health Qual Life Outcomes
2019
;
17
:
36
.

14

Gomes-Neto
M
,
Durães
AR
,
Conceição
LSR
,
Roever
L
,
Silva
CM
,
Alves
IGN
, et al.
Effect of combined aerobic and resistance training on peak oxygen consumption, muscle strength and health-related quality of life in patients with heart failure with reduced left ventricular ejection fraction: a systematic review and meta-analysis
.
Int J Cardiol
2019
;
293
:
165
175
.

Author notes

A part of the work in this article was presented at the ESC Preventive Cardiology congress in 2022.

Conflict of interest: None declared.

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://dbpia.nl.go.kr/pages/standard-publication-reuse-rights)

Supplementary data

Comments

0 Comments
Submit a comment
You have entered an invalid code
Thank you for submitting a comment on this article. Your comment will be reviewed and published at the journal's discretion. Please check for further notifications by email.